All In Biotech

Drug Trial Radar · NCT06926842

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes

Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 221 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

221

Actual

Start

Apr 22, 2025

Primary completion

Aug 13, 2026

Study completion Aug 13, 2026

Sponsor

Lead sponsor
Zealand PharmaIndustry
Sponsor type
Industry
Collaborators
Parexel
First posted
Apr 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes.

Conditions

  • Overweight
  • Type 2 Diabetes
  • Obesity

Interventions

  • PetrelintideDrug

    Petrelintide will be taken by participants once weekly subcutaneously.

  • PlaceboOther

    Matching placebo to petrelintide will be taken by participants once weekly subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage Change in Body WeightTime frame: From Baseline (Day 1) to Weeks 28

Locations

48 sites in 1 country. Site status is shown where the registry gives one.

  • Cullman Clinical Trials - Family Medicine

    Cullman, Alabama

  • AZ Endocrine Institute

    Chandler, Arizona

  • Elite Clinical Studies, LLC

    Phoenix, Arizona

  • M3 Wake Research, Tucson Neuroscience Research, LLC

    Tucson, Arizona

  • Medical Investigation Inc

    Little Rock, Arkansas

  • Velocity Clinical Research

    Huntington Park, California

  • Velocity Clinical Research, North Hollywood

    North Hollywood, California

  • Exalt Clinical Research

    San Diego, California

  • Diablo Clinical Research Inc.

    Walnut Creek, California

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Emerson Clinical Research

    Washington D.C., District of Columbia

  • Innovative Research of West Florida

    Clearwater, Florida

  • East Coast Institute for Research, LLC

    Jacksonville, Florida

  • Solutions Through Advanced Research, Inc

    Jacksonville, Florida

  • M3 Wake Research - Lake City

    Lake City, Florida

  • West Orange Endocrinology P.A

    Ocoee, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • M3 Wake Research - Atlanta

    Atlanta, Georgia

  • East Coast Institute for Research - Canton

    Canton, Georgia

  • Privia Medical Group Georgia, LLC

    Savannah, Georgia

  • Great Lakes Clinical Trials

    Chicago, Illinois

  • Iowa Diabetes & Endocrinology Research Center

    West Des Moines, Iowa

  • Heartland Research Associates, LLC

    Wichita, Kansas

  • DelRicht Research - New Orleans

    New Orleans, Louisiana

  • AAMRC

    Flint, Michigan

  • International Diabetes Center

    Minneapolis, Minnesota

  • Velocity Clinical Research, Gulfport

    Gulfport, Mississippi

  • AMR Kansas City

    Kansas City, Missouri

  • Mercury Street Medical Group, PLLC

    Butte, Montana

  • M3 Wake Research - Las Vegas, NV

    Las Vegas, Nevada

  • Palm Research Center, Inc.

    Las Vegas, Nevada

  • Javara Inc

    Charlotte, North Carolina

  • PharmQuest Life Sciences, LLC

    Greensboro, North Carolina

  • M3 Wake Research

    Raleigh, North Carolina

  • Velocity Clinical Research, Cincinnati, Mt. Auburn

    Cincinnati, Ohio

  • Centricity Research

    Columbus, Ohio

  • Lynn Institute of Norman

    Norman, Oklahoma

  • M3 Wake Research - Charleston

    Charleston, South Carolina

  • M3 Wake Research/ClinSearch, LLC

    Chattanooga, Tennessee

  • Elligo Clinical Research, Inc.

    Austin, Texas

Showing 40 of 48 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.